• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,562.59 -847.39
( -1.09%)
Global Indices
Nasdaq
51,584.84 71.29
(0.14%)
Dow Jones
7,519.91 78.81
(1.06%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,394.87 -113.74
(-1.08%)
Forex
USD-INR
94.51 -0.04
(-0.04%)
EUR-INR
109.43 -0.23
(-0.21%)
GBP-INR
126.51 -0.33
(-0.26%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Vivo Bio Tech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
511509
INE380K01017
41.2789706
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
53.32
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Rajkamal Synthetics standalone net profit declines 41.67% in the March 2026 quarter
May 30,2026
Net profit of Rajkamal Synthetics declined 41.67% to Rs 0.07 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025. Sales declined 6.45% to Rs 1.16 crore in the quarter ended March 2026 as against Rs 1.24 crore during the previous quarter ended March 2025.

For the full year,net profit rose 18.18% to Rs 0.26 crore in the year ended March 2026 as against Rs 0.22 crore during the previous year ended March 2025. Sales rose 174.88% to Rs 5.69 crore in the year ended March 2026 as against Rs 2.07 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.161.24 -6 5.692.07 175
OPM %6.0315.32 -6.6814.49 -
PBDT0.100.17 -41 0.410.28 46
PBT0.080.17 -53 0.330.27 22
NP0.070.12 -42 0.260.22 18